Stock Events

Stock Events

CytoMed Therapeutics (GDTC) Q3 2024 Earnings

30SepConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.07

-0.05

-0.02

0

Details

Expected EPS

N/A

Actual EPS

-0.07

Surprise EPS

-0.07

Surprise Percent

+∞%

Description

CytoMed Therapeutics (GDTC) has reported earnings of -0.07 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.